{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:27:33Z","timestamp":1790908053602,"version":"4.1.0"},"reference-count":227,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-031830"],"award-info":[{"award-number":["INV-031830"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>The complex intracellular pathogens <jats:italic>Mycobacterium tuberculosis<\/jats:italic>, <jats:italic>Mycobacterium leprae<\/jats:italic>, <jats:italic>Leishmania<\/jats:italic> spp., and <jats:italic>Burkholderia pseudomallei<\/jats:italic>, which cause tuberculosis, leprosy, leishmaniasis, and melioidosis respectively, represent major health threats with a significant global burden concentrated in low- and middle-income countries. While these diseases vary in their aetiology, pathology and epidemiology, they share key similarities in the biological and sociodemographic factors influencing their incidence and impact worldwide. In particular, their occurrence in resource-limited settings has important implications for research and development, disease prevalence and associated risk factors, as well as access to diagnostics and therapeutics. In accordance with the vision of the VALIDATE (VAccine deveLopment for complex Intracellular neglecteD pAThogeEns) Network, we consider shared challenges to the effective prevention, diagnosis and treatment of these diseases as shaped by both biological and social factors, illustrating the importance of taking an interdisciplinary approach. We further highlight how a cross-pathogen perspective may provide valuable insights for understanding and addressing challenges to the control of all four pathogens.<\/jats:p>","DOI":"10.3389\/fpubh.2024.1423420","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T04:21:33Z","timestamp":1726028493000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Shared challenges to the control of complex intracellular neglected pathogens"],"prefix":"10.3389","volume":"12","author":[{"given":"Rebecca Lynn","family":"Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemima","family":"Chase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-031-24355-4","volume-title":"Vaccines for neglected pathogens: strategies, achievements and challenges: focus on leprosy, leishmaniasis, melioidosis and tuberculosis","author":"Christodoulides","year":"2023"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.12688\/f1000research.14386.1","article-title":"VALIDATE: exploiting the synergy between complex intracellular pathogens to expedite vaccine research and development for tuberculosis, leishmaniasis, melioidosis and leprosy","volume":"7","author":"Fletcher","year":"2018","journal-title":"F1000Res"},{"key":"ref3","first-page":"2929","article-title":"Live Mycobacterium leprae inhibits autophagy and apoptosis of infected macrophages and prevents engulfment of host cell by phagocytes","volume":"10","author":"Ma","year":"2018","journal-title":"Am J Transl Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fmicb.2011.00170","article-title":"Strategies for intracellular survival of Burkholderia pseudomallei","volume":"2","author":"Adler","year":"2011","journal-title":"Front Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fcimb.2012.00083","article-title":"The early interaction of Leishmania with macrophages and dendritic cells and its influence on the host immune response","volume":"2","author":"Liu","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.3389\/fmicb.2017.02284","article-title":"The macrophage: a disputed fortress in the Battle against Mycobacterium tuberculosis","volume":"8","author":"Queval","year":"2017","journal-title":"Front Microbiol"},{"key":"ref7","year":"2010"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40249-020-0630-9","article-title":"Neglected tropical diseases: an effective global response to local poverty-related disease priorities","volume":"9","author":"Engels","year":"2020","journal-title":"Infect Dis Poverty"},{"key":"ref9","year":"2020"},{"key":"ref10","volume-title":"Leprosy (Hansen's disease)","year":"2021"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s13071-015-1143-4","article-title":"Global elimination of leprosy by 2020: are we on track?","volume":"8","author":"Blok","year":"2015","journal-title":"Parasit Vectors"},{"key":"ref12","year":"2021"},{"key":"ref13","volume-title":"Leishmaniasis","year":"2021"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e0000027","DOI":"10.1371\/journal.pgph.0000027","article-title":"Comparison and lessons learned from neglected tropical diseases and tuberculosis","volume":"1","author":"Wang","year":"2021","journal-title":"PLOS Global Public Health"},{"key":"ref15","year":"2020"},{"key":"ref16","year":"2013"},{"key":"ref17","year":"2020"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"17107","DOI":"10.1038\/nrdp.2017.107","article-title":"Melioidosis","volume":"4","author":"Wiersinga","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/S1473-3099(19)30157-4","article-title":"Global burden of melioidosis in 2015: a systematic review and data synthesis","volume":"19","author":"Birnie","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/trstmh\/try124","article-title":"The double burden of diabetes and global infection in low and middle-income countries","volume":"113","author":"Dunachie","year":"2019","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/trstmh\/trz132","article-title":"Stigma, participation restriction and mental distress in patients affected by leprosy, cutaneous leishmaniasis and Chagas disease: a pilot study in two co-endemic regions of eastern Colombia","volume":"114","author":"G\u00f3mez","year":"2020","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"i7","DOI":"10.1093\/inthealth\/ihw001","article-title":"Neglected tropical diseases, cross-cutting issues workshop, 4\u20136 February 2015, Utrecht, the Netherlands: meeting report","volume":"8","author":"Mieras","year":"2016","journal-title":"Int Health"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/tropicalmed2030036","article-title":"Neglected tropical diseases: epidemiology and global burden","volume":"2","author":"Mitra","year":"2017","journal-title":"Trop Med Infect Dis"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e0203407","DOI":"10.1371\/journal.pone.0203407","article-title":"Knowledge, stigma, health seeking behaviour and its determinants among patients with post kalaazar dermal leishmaniasis, Bihar, India","volume":"13","author":"Garapati","year":"2018","journal-title":"PLoS One"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.47276\/lr.85.1.36","article-title":"Stigma in leprosy: concepts, causes and determinants","volume":"85","author":"Sermrittirong","year":"2014","journal-title":"Lepr Rev"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1080\/17476348.2020.1826314","article-title":"Tuberculosis related stigma in India: roadblocks and the way forward","volume":"15","author":"Thomas","year":"2021","journal-title":"Expert Rev Respir Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.coi.2014.02.003","article-title":"Novel vaccine approaches for protection against intracellular pathogens","volume":"28","author":"Griffiths","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis","volume":"22","author":"Rodrigues","year":"1993","journal-title":"Int J Epidemiol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1586\/erv.09.161","article-title":"BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control","volume":"9","author":"Merle","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0140-6736(95)91421-8","article-title":"Immunological conditions of children with BCG disseminated infection","volume":"346","author":"Casanova","year":"1995","journal-title":"Lancet"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.3390\/app10072632","article-title":"Update on TB vaccine pipeline","volume":"10","author":"Martin","year":"2020","journal-title":"Appl Sci"},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.1201\/9781351249980-12","article-title":"BCG and other vaccines","volume-title":"Cinical Tuberculosis","author":"Tanner","year":"2020"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.25259\/JSSTD_24_2020","article-title":"Leprosy vaccines\u2013a voyage unfinished","volume":"3","author":"Ali","year":"2021","journal-title":"J Skin Sexually Trans Dis"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/ijpvm.IJPVM_116_18","article-title":"Leishmania vaccines entered in clinical trials: a review of literature","volume":"10","author":"Moafi","year":"2019","journal-title":"Int J Prev Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e00724","DOI":"10.1128\/IAI.00724-17","article-title":"Development of subunit vaccines that provide high-level protection and sterilizing immunity against acute inhalational melioidosis","volume":"86","author":"Burtnick Mary","year":"2018","journal-title":"Infect Immun"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.smim.2018.10.001","article-title":"Systems approaches to correlates of protection and progression to TB disease","volume":"39","author":"Fletcher","year":"2018","journal-title":"Semin Immunol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1128\/CVI.00721-14","article-title":"Quest for correlates of protection against tuberculosis","volume":"22","author":"Bhatt","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.3389\/fimmu.2019.02983","article-title":"Tools for assessing the protective efficacy of TB vaccines in humans: in vitro mycobacterial growth inhibition predicts outcome of in vivo mycobacterial infection","volume":"10","author":"Tanner","year":"2020","journal-title":"Front Immunol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1016\/j.vaccine.2016.07.058","article-title":"In vitro mycobacterial growth inhibition assays: a tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy","volume":"34","author":"Tanner","year":"2016","journal-title":"Vaccine"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1164\/rccm.201912-2408ED","article-title":"Controlled human infection models: is it really feasible to give people tuberculosis?","volume":"201","author":"McShane","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3389\/fimmu.2018.00308","article-title":"Vaccines for leprosy and tuberculosis: opportunities for shared research, development, and application","volume":"9","author":"Coppola","year":"2018","journal-title":"Front Immunol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40249-016-0229-3","article-title":"The influence of innate and adaptative immune responses on the differential clinical outcomes of leprosy","volume":"6","author":"de Lima Fonseca","year":"2017","journal-title":"Infect Dis Poverty"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"155247","DOI":"10.1016\/j.cyto.2020.155247","article-title":"Th1 concomitant immune response mediated by IFN-\u03b3 protects against sand fly delivered leishmania infection: implications for vaccine design","volume":"147","author":"Seyed","year":"2021","journal-title":"Cytokine"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.3389\/fimmu.2021.767359","article-title":"BpOmpW antigen stimulates the necessary protective T-cell responses against melioidosis","volume":"12","author":"Tom\u00e1s-Cort\u00e1zar","year":"2021","journal-title":"Front Immunol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tube.2013.11.003","article-title":"A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data","volume":"94","author":"McShane","year":"2014","journal-title":"Tuberculosis (Edinb)"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"4263079","DOI":"10.1155\/2020\/4263079","article-title":"Animal models of tuberculosis vaccine research: an important component in the fight against tuberculosis","volume":"2020","author":"Gong","year":"2020","journal-title":"Biomed Res Int"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1590\/s1678-9946201961044","article-title":"Armadillos and leprosy: from infection to biological model","volume":"61","author":"Oliveira","year":"2019","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"338","DOI":"10.47276\/lr.78.4.338","article-title":"Is there a role for a vaccine in leprosy control?","volume":"78","author":"Gillis","year":"2007","journal-title":"Lepr Rev"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","article-title":"Leishmaniasis: current status of vaccine development","volume":"14","author":"Handman","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/cei.13286","article-title":"Novel multi-component vaccine approaches for Burkholderia pseudomallei","volume":"196","author":"Morici","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/infdis\/jis012","article-title":"A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guerin","volume":"205","author":"Minassian","year":"2012","journal-title":"J Infect Dis"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/infdis\/jit647","article-title":"Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination","volume":"209","author":"Harris","year":"2014","journal-title":"J Infect Dis"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.tube.2017.05.001","article-title":"Pilot studies of a human BCG challenge model","volume":"105","author":"Blazevic","year":"2017","journal-title":"Tuberculosis (Edinb)"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S1473-3099(24)00143-9","article-title":"Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial","volume":"24","author":"Satti","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/j.tube.2016.05.010","article-title":"TB biomarkers, TB correlates and human challenge models: new tools for improving assessment of new TB vaccines","volume":"99","author":"Kaufmann","year":"2016","journal-title":"Tuberculosis"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0039-6257(02)00285-0","article-title":"The ophthalmic trials of G. H. A. Hansen","volume":"47","author":"Marmor","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41467-020-20569-3","article-title":"Characterization of a new leishmania major strain for use in a controlled human infection model","volume":"12","author":"Ashwin","year":"2021","journal-title":"Nat Commun"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1080\/14760584.2021.1991795","article-title":"Vaccines against leishmaniasis: using controlled human infection models to accelerate development","volume":"20","author":"Parkash","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"e0192413","DOI":"10.1371\/journal.pone.0192413","article-title":"Global migration of clinical research during the era of trial registration","volume":"13","author":"Drain","year":"2018","journal-title":"PLoS One"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12939-018-0748-6","article-title":"Barriers for conducting clinical trials in developing countries- a systematic review","volume":"17","author":"Alemayehu","year":"2018","journal-title":"Int J Equity Health"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"e252","DOI":"10.1371\/journal.pmed.0040252","article-title":"Development of new tuberculosis vaccines: a global perspective on regulatory issues","volume":"4","author":"Brennan","year":"2007","journal-title":"PLoS Med"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"e20152800","DOI":"10.1542\/peds.2015-2800","article-title":"Stakeholder views of clinical trials in Low- and middle-income countries: a systematic review","volume":"137","author":"Joseph","year":"2016","journal-title":"Pediatrics"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-021-00279-w","article-title":"Overcoming vaccine hesitancy in low-income and middle-income regions","volume":"7","author":"Simas","year":"2021","journal-title":"Nat Rev Dis Prim"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/archdischild-2020-318988","article-title":"Vaccine hesitancy in low- and middle-income countries: potential implications for the COVID-19 response","volume":"106","author":"Bhopal","year":"2021","journal-title":"Arch Dis Child"},{"key":"ref68","year":"2020"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.4049\/jimmunol.172.7.4592","article-title":"Mycobacterium tuberculosis resides in nonacidified vacuoles in endocytically competent alveolar macrophages from patients with tuberculosis and HIV infection","volume":"172","author":"Mwandumba","year":"2004","journal-title":"J Immunol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.cell.2007.05.059","article-title":"M. Tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells","volume":"129","author":"van der Wel","year":"2007","journal-title":"Cell"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1084\/jem.193.3.271","article-title":"The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice","volume":"193","author":"Mogues","year":"2001","journal-title":"J Exp Med"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S1473-3099(06)70493-5","article-title":"Interactions between HIV infection and leprosy: a paradox","volume":"6","author":"Ustianowski","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1086\/653839","article-title":"Leprosy and HIV coinfection: a clinical, pathological, immunological, and therapeutic study of a cohort from a Brazilian referral center for infectious diseases","volume":"202","author":"Talhari","year":"2010","journal-title":"J Infect Dis"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"e0003818","DOI":"10.1371\/journal.pntd.0003818","article-title":"Leprosy reactions in patients Coinfected with HIV: clinical aspects and outcomes in two comparative cohorts in the Amazon Region, Brazil","volume":"9","author":"Pires","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2147\/HIV.S93789","article-title":"Leishmaniasis-HIV coinfection: current challenges","volume":"8","author":"Lindoso","year":"2016","journal-title":"HIV\/AIDS"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2147\/HIV.S143929","article-title":"Visceral leishmaniasis and HIV coinfection: current perspectives","volume":"10","author":"Lindoso","year":"2018","journal-title":"HIV\/AIDS"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"e1002635","DOI":"10.1371\/journal.ppat.1002635","article-title":"Leishmania induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection","volume":"8","author":"Mock","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.4269\/ajtmh.2005.73.1165","article-title":"Short report: disease severity and outcome of melioidosis in HIV coinfected individuals","volume":"73","author":"Chierakul","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1086\/498983","article-title":"Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection","volume":"193","author":"Haque","year":"2006","journal-title":"J Infect Dis"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"04040","DOI":"10.7189\/jogh.11.04040","article-title":"Diabetes comorbidities in low- and middle-income countries: an umbrella review","volume":"11","author":"Lam","year":"2021","journal-title":"J Glob Health"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.jdiacomp.2018.08.003","article-title":"Glycemic reduction alters white blood cell counts and inflammatory gene expression in diabetes","volume":"32","author":"Fang","year":"2018","journal-title":"J Diabetes Complicat"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cccn.2004.03.026","article-title":"In vitro glycation of human immunoglobulin G","volume":"345","author":"Vrdoljak","year":"2004","journal-title":"Clin Chim Acta"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1681\/ASN.2008050555","article-title":"Reactive immunization suppresses advanced glycation and mitigates diabetic nephropathy","volume":"20","author":"Shcheglova","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"ref85","volume-title":"Glycation of human IgG induces structural alterations leading to changes in its interaction with anti-IgG. Iran_J_Immunol, IJI","author":"Goudarzi","year":"2005"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/imm.12421","article-title":"Type 2 diabetes mellitus is associated with altered CD8(+) T and natural killer cell function in pulmonary tuberculosis","volume":"144","author":"Kumar","year":"2015","journal-title":"Immunology"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/cmi.2015.116","article-title":"Impaired T-cell differentiation in diabetic foot ulceration","volume":"14","author":"Moura","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"e000379","DOI":"10.1136\/bmjdrc-2016-000379","article-title":"Individuals with obesity and type 2 diabetes have additional immune dysfunction compared with obese individuals who are metabolically healthy","volume":"5","author":"Richard","year":"2017","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.3389\/fimmu.2020.01582","article-title":"The effects of type 2 diabetes mellitus on organ metabolism and the immune system","volume":"11","author":"Daryabor","year":"2020","journal-title":"Front Immunol"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.micinf.2020.03.004","article-title":"Increased susceptibility to Mycobacterium tuberculosis infection in a diet-induced murine model of type 2 diabetes","volume":"22","author":"Alim","year":"2020","journal-title":"Microbes Infect"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/eji.201344301","article-title":"Diabetes and immunity to tuberculosis","volume":"44","author":"Martinez","year":"2014","journal-title":"Eur J Immunol"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"TNMI7-0023-2016","DOI":"10.1128\/microbiolspec.TNMI7-0023-2016","article-title":"Diabetes and tuberculosis","volume":"4","author":"Restrepo","year":"2016","journal-title":"MicrobiolSpectrum"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1016\/j.tube.2019.04.015","article-title":"The re-emerging association between tuberculosis and diabetes: lessons from past centuries","volume":"116","author":"Cadena","year":"2019","journal-title":"Tuberculosis (Edinb)"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/S2213-8587(14)70230-X","article-title":"Diabetes and tuberculosis in the Pacific Islands region","volume":"2","author":"Viney","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3201\/eid2303.161053","article-title":"Association of diabetes and tuberculosis disease among US-bound adult refugees, 2009\u20132014","volume":"23","author":"Benoit","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/cid\/ciaa751","article-title":"Impact of intermediate hyperglycemia and diabetes on immune dysfunction in Tuberculosis","volume":"72","author":"Eckold","year":"2020","journal-title":"Clin Infect Dis"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"152","DOI":"10.21037\/apm.2020.02.16","article-title":"The impact of diabetes mellitus on drug resistance in patients with newly diagnosed tuberculosis: a systematic review and meta-analysis","volume":"9","author":"Huang","year":"2020","journal-title":"Ann Palliat Med"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"7","DOI":"10.47878\/hi.1979.v4.35626","article-title":"Diabetic status in leprosy","volume":"4","author":"Nigam","year":"1979","journal-title":"Hansen Int"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jiph.2012.08.001","article-title":"Diabetic status of patients with leprosy in Kuwait","volume":"5","author":"Saraya","year":"2012","journal-title":"J Infect Public Health"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/j.1365-3156.2004.01328.x","article-title":"Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia","volume":"9","author":"Currie","year":"2004","journal-title":"Trop Med Int Health"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1086\/507632","article-title":"Risk factors for recurrent melioidosis in Northeast Thailand","volume":"43","author":"Limmathurotsakul","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/eji.201848037","article-title":"Diabetes alters immune response patterns to acute melioidosis in humans","volume":"49","author":"Kronsteiner","year":"2019","journal-title":"Eur J Immunol"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1128\/IAI.00503-08","article-title":"Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects","volume":"77","author":"Chanchamroen","year":"2009","journal-title":"Infect Immun"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1128\/IAI.00930-12","article-title":"Impaired early cytokine responses at the site of infection in a murine model of type 2 diabetes and melioidosis comorbidity","volume":"81","author":"Hodgson","year":"2013","journal-title":"Infect Immun"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1172\/JCI57817","article-title":"Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria","volume":"122","author":"Tan","year":"2012","journal-title":"J Clin Invest"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.imlet.2021.07.001","article-title":"Impairment of effector molecules response in diabetes induces susceptibility to Leishmania amazonensis infection","volume":"237","author":"Silva","year":"2021","journal-title":"Immunol Lett"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"e0008393","DOI":"10.1371\/journal.pntd.0008393","article-title":"Comorbidities associated with non- healing of plantar ulcers in leprosy patients","volume":"14","author":"Upputuri","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"e0121418","DOI":"10.1371\/journal.pone.0121418","article-title":"Visceral Leishmaniasis and Immunocompromise as a risk factor for the development of visceral leishmaniasis: a changing pattern at the Hospital for Tropical Diseases, London","volume":"10","author":"Fletcher","year":"2015","journal-title":"PLoS One"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1128\/CMR.00042-10","article-title":"HIV and Tuberculosis: a deadly human Syndemic","volume":"24","author":"Kwan Candice","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"e0203986","DOI":"10.1371\/journal.pone.0203986","article-title":"The twin epidemics: prevalence of TB\/HIV co-infection and its associated factors in Ethiopia; a systematic review and meta-analysis","volume":"13","author":"Tesfaye","year":"2018","journal-title":"PLoS One"},{"key":"ref111","first-page":"288","article-title":"Excess and access: the continuing controversy regarding HIV and health care in Africa","volume":"12","author":"Charles","year":"2002","journal-title":"AIDS Read"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.3390\/ijerph18105124","article-title":"Assessing factors associated with TB awareness in Nepal: a national and subnational study","volume":"18","author":"Iwaki","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2334-13-16","article-title":"Prevalence of self-reported tuberculosis, knowledge about tuberculosis transmission and its determinants among adults in India: results from a nation-wide cross-sectional household survey","volume":"13","author":"Sreeramareddy","year":"2013","journal-title":"BMC Infect Dis"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"e0206245","DOI":"10.1371\/journal.pone.0206245","article-title":"Knowledge about tuberculosis and infection prevention behavior: a nine city longitudinal study from India","volume":"13","author":"Huddart","year":"2018","journal-title":"PLoS One"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"e0007302","DOI":"10.1371\/journal.pntd.0007302","article-title":"The role of perceptions and knowledge of leprosy in the elimination of leprosy: a baseline study in Fatehpur district, northern India","volume":"13","author":"Van\u2019t Noordende","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1111\/j.1468-3083.2011.04339.x","article-title":"Public awareness and attitudes towards cutaneous leishmaniasis in an endemic region in Saudi Arabia","volume":"26","author":"Amin","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"566","DOI":"10.12980\/APJTB.4.2014C744","article-title":"Knowledge, attitude, and practices related to cutaneous leishmaniasis in an endemic focus of cutaneous leishmaniasis, southern Iran","volume":"4","author":"Sarkari","year":"2014","journal-title":"Asian Pac J Trop Biomed"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"e1000257","DOI":"10.4172\/2329-891X.1000257","article-title":"Knowledge attitude and practice towards visceral leishmaniasis among residents and health professionals in welkait district, western Tigray, Ethiopia","volume":"6","author":"Berhe","year":"2018","journal-title":"J Trop Dis"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/1896210","article-title":"2020, \"the cutaneous Leishmaniasis and the sand Fly: knowledge and beliefs of the population in Central Morocco (El Hajeb),\"","volume":"2020","author":"El-Mouhdi","year":"2020","journal-title":"Dermatol Res Pract"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4103\/0972-9062.191335","article-title":"Challenges in visceral leishmaniasis control and elimination in the developing countries: a review","volume":"53","author":"Hailu","year":"2016","journal-title":"J Vector Borne Dis"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.inhe.2009.12.002","article-title":"Some sociological aspects of cutaneous leishmaniasis in patients attending a tertiary referral Centre in Colombo, Sri Lanka","volume":"2","author":"Fernando","year":"2010","journal-title":"Int Health"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"e0004823","DOI":"10.1371\/journal.pntd.0004823","article-title":"Barriers and recommended interventions to prevent melioidosis in Northeast Thailand: a focus group study using the behaviour change wheel","volume":"10","author":"Suntornsut","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"e0121311","DOI":"10.1371\/journal.pone.0121311","article-title":"Public awareness of melioidosis in Thailand and potential use of video clips as educational tools","volume":"10","author":"Chansrichavala","year":"2015","journal-title":"PLoS One"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3961\/jpmph.20.094","article-title":"Impact of rumors and misinformation on COVID-19 in social media","volume":"53","author":"Tasnim","year":"2020","journal-title":"J Prev Med Public Health"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1196\/annals.1425.011","article-title":"Poverty and access to Health Care in Developing Countries","volume":"1136","author":"Peters","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2458-8-15","article-title":"A systematic review of delay in the diagnosis and treatment of tuberculosis","volume":"8","author":"Storla","year":"2008","journal-title":"BMC Public Health"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"e0006778","DOI":"10.1371\/journal.pntd.0006778","article-title":"Barriers to access to visceral leishmaniasis diagnosis and care among seasonal mobile workers in Western Tigray, northern Ethiopia: a qualitative study","volume":"12","author":"Coulborn","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"ref128","first-page":"24","article-title":"Gender difference in delays to diagnosis and health care seeking behaviour in a rural area of Nepal","volume":"5","author":"Yamasaki-Nakagawa","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref129","year":"2017"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1056\/NEJMoa0907488","article-title":"An algorithm for tuberculosis screening and diagnosis in people with HIV","volume":"362","author":"Cain","year":"2010","journal-title":"N Engl J Med"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S1473-3099(16)30090-1","article-title":"What do we actually know about leprosy worldwide?","volume":"16","author":"Salgado","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s12639-020-01212-w","article-title":"Leishmaniasis diagnosis: an update on the use of parasitological, immunological and molecular methods","volume":"44","author":"Thakur","year":"2020","journal-title":"J Parasit Dis"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1590\/0074-02760140280","article-title":"Accuracy of mucocutaneous leishmaniasis diagnosis using polymerase chain reaction: systematic literature review and meta-analysis","volume":"110","author":"Gomes","year":"2015","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.apjtm.2016.04.003","article-title":"Pitfalls and optimal approaches to diagnose melioidosis","volume":"9","author":"Kingsley","year":"2016","journal-title":"Asian Pac J Trop Med"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1164\/rccm.201405-0967OC","article-title":"Risk assessment of tuberculosis in immunocompromised patients. A TBNET study","volume":"190","author":"Sester","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/1469-0691.12556","article-title":"Leishmaniasis in immunosuppressed individuals","volume":"20","author":"van Griensven","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"929","DOI":"10.4269\/ajtmh.2009.80.929","article-title":"Field evaluation of rK39 test and direct agglutination test for diagnosis of visceral leishmaniasis in a population with high prevalence of human immunodeficiency virus in Ethiopia","volume":"80","author":"ter Horst","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"ref138","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/B978-1-4160-3988-4.00019-6","article-title":"Chapter 19 - immune-based tests for tuberculosis","volume-title":"Tuberculosis","author":"Menzies","year":"2009"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/diagnostics8040078","article-title":"Challenges and Progress with diagnosing pulmonary Tuberculosis in Low- and middle-income countries","volume":"8","author":"Harries","year":"2018","journal-title":"Diagnostics (Basel, Switzerland)"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.2214\/AJR.04.0751","article-title":"Pulmonary tuberculosis in infants: radiographic and CT findings","volume":"187","author":"Kim","year":"2006","journal-title":"AJR Am J Roentgenol"},{"key":"ref141","year":"2017"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.clindermatol.2014.07.005","article-title":"Immunology of leprosy and diagnostic challenges","volume":"33","author":"Nath","year":"2015","journal-title":"Clin Dermatol"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"e0004638","DOI":"10.1371\/journal.pntd.0004638","article-title":"An innovative Field-applicable molecular test to diagnose cutaneous Leishmania Viannia spp. infections","volume":"10","author":"Saldarriaga","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"971","DOI":"10.4269\/ajtmh.13-0212","article-title":"Rapid detection of Burkholderia pseudomallei in blood cultures using a monoclonal antibody-based immunofluorescent assay","volume":"89","author":"Chantratita","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"e0175294","DOI":"10.1371\/journal.pone.0175294","article-title":"Matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry for the identification of Burkholderia pseudomallei from Asia and Australia and differentiation between Burkholderia species","volume":"12","author":"Suttisunhakul","year":"2017","journal-title":"PLoS One"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/tmi.13023","article-title":"Factors associated with the delay of diagnosis of leprosy in North-Eastern Colombia: a quantitative analysis","volume":"23","author":"G\u00f3mez","year":"2018","journal-title":"Trop Med Int Health"},{"key":"ref147","first-page":"473","article-title":"A 5-year retrospective study of melioidosis cases treated in a district specialist hospital","volume":"74","author":"Toh","year":"2019","journal-title":"Med J Malaysia"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"320","DOI":"10.4103\/1995-7645.233179","article-title":"Melioidosis in India and Bangladesh: a review of case reports","volume":"11","author":"Tipre","year":"2018","journal-title":"Asian Pac J Trop Med"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"938","DOI":"10.5588\/ijtld.10.0211","article-title":"Tuberculosis knowledge, attitudes and health-seeking behaviour in rural Uganda","volume":"15","author":"Buregyeya","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-019-7915-6","article-title":"Stigma matters in ending tuberculosis: Nationwide survey of stigma in Ethiopia","volume":"20","author":"Datiko","year":"2020","journal-title":"BMC Public Health"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5588\/ijtld.16.0920","article-title":"Secondary analysis of tuberculosis stigma data from a cluster randomised trial in Zambia and South Africa (ZAMSTAR)","volume":"21","author":"Bond","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1177\/1049732308322596","article-title":"Perception and management of tuberculosis symptoms in Addis Ababa, Ethiopia","volume":"18","author":"Sagbakken","year":"2008","journal-title":"Qual Health Res"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"58","DOI":"10.47276\/lr.88.1.58","article-title":"Stigmatisation and discrimination: experiences of people affected by leprosy in southern Ghana","volume":"88","author":"Dako-Gyeke","year":"2017","journal-title":"Lepr Rev"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"18394","DOI":"10.3402\/gha.v5i0.18394","article-title":"Disability in people affected by leprosy: the role of impairment, activity, social participation, stigma and discrimination","volume":"5","author":"Van Brakel","year":"2012","journal-title":"Glob Health Action"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"119","DOI":"10.47276\/lr.76.2.119","article-title":"Curing the stigma of leprosy","volume":"76","author":"Rafferty","year":"2005","journal-title":"Lepr Rev"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"e0004542","DOI":"10.1371\/journal.pntd.0004542","article-title":"Factors contributing to the delay in diagnosis and continued transmission of leprosy in Brazil\u2013an explorative, quantitative, questionnaire based study","volume":"10","author":"Henry","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"489","DOI":"10.4269\/ajtmh.15-0408","article-title":"Social and economic burden of human leishmaniasis","volume":"94","author":"Okwor","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4103\/jfmpc.jfmpc_171_17","article-title":"Splenic granuloma: melioidosis or tuberculosis?","volume":"7","author":"Ninan","year":"2018","journal-title":"J Family Med Prim Care"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.arbres.2022.07.012","article-title":"Rapid diagnosis of XDR and pre-XDR TB: a systematic review of available tools","volume":"58","author":"Saderi","year":"2022","journal-title":"Arch Bronconeumol"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.cmi.2018.02.022","article-title":"Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009\u201315","volume":"24","author":"Cambau","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"e0003518","DOI":"10.1371\/journal.pntd.0003518","article-title":"Arsenic exposure and outcomes of antimonial treatment in visceral leishmaniasis patients in Bihar, India: a retrospective cohort study","volume":"9","author":"Perry","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1017\/S0031182016002031","article-title":"Evaluating drug resistance in visceral leishmaniasis: the challenges","volume":"145","author":"Hendrickx","year":"2018","journal-title":"Parasitology"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"e0006052","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"ref164","year":"2010"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"e0004304","DOI":"10.1371\/journal.pntd.0004304","article-title":"Antimony to cure visceral Leishmaniasis unresponsive to liposomal amphotericin B","volume":"10","author":"Morizot","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"ref166","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12879-017-2192-4","article-title":"A severe case of visceral leishmaniasis and liposomal amphotericin B treatment failure in an immunosuppressed patient 15 years after exposure","volume":"17","author":"Eichenberger","year":"2017","journal-title":"BMC Infect Dis"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1128\/AAC.00030-11","article-title":"Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani","volume":"56","author":"Purkait","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3201\/eid2502.170745","article-title":"Clinical manifestations, antimicrobial drug susceptibility patterns, and outcomes in melioidosis cases, India","volume":"25","author":"Koshy","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2147\/IMCRJ.S173461","article-title":"Pan-drug-resistant and biofilm-producing strain of Burkholderia pseudomallei: first report of melioidosis from a diabetic patient in Yogyakarta, Indonesia","volume":"11","author":"Nuryastuti","year":"2018","journal-title":"Int Med Case Rep J"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"5388","DOI":"10.1128\/AAC.05517-11","article-title":"Survey of antimicrobial resistance in clinical Burkholderia pseudomallei isolates over two decades in Northeast Thailand","volume":"55","author":"Wuthiekanun","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0924-8579(02)00016-X","article-title":"A comparison of antibiotic susceptibility testing methods for cotrimoxazole with Bukholderia pseudomallei","volume":"19","author":"Piliouras","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"ref172","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.3389\/fmicb.2018.03072","article-title":"Insights on Mycobacterium leprae efflux pumps and their implications in drug resistance and virulence","volume":"9","author":"Machado","year":"2018","journal-title":"Front Microbiol"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0924-8579(03)00211-5","article-title":"Leishmaniasis: efflux pumps and chemoresistance","volume":"22","author":"Leandro","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"ref174","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/S0140-6736(03)13374-0","article-title":"Melioidosis","volume":"361","author":"White","year":"2003","journal-title":"Lancet"},{"key":"ref175","doi-asserted-by":"publisher","DOI":"10.3390\/app10062153","article-title":"Drug-resistant tuberculosis 2020: where we stand","volume":"10","author":"Iacobino","year":"2020","journal-title":"Appl Sci"},{"key":"ref176","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.drudis.2017.01.002","article-title":"Antituberculosis drugs: reducing efflux=increasing activity","volume":"22","author":"Rodrigues","year":"2017","journal-title":"Drug Discov Today"},{"key":"ref177","doi-asserted-by":"publisher","first-page":"e02107","DOI":"10.1128\/AAC.02107-17","article-title":"Verapamil targets membrane energetics in Mycobacterium tuberculosis","volume":"62","author":"Chen","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"ref178","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ijantimicag.2012.01.012","article-title":"Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections","volume":"39","author":"Amaral","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"ref179","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/pro.324","article-title":"Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities","volume":"19","author":"Cade","year":"2010","journal-title":"Protein Sci"},{"key":"ref180","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jmb.2004.10.020","article-title":"Structural characterization of the Ser324Thr variant of the catalase-peroxidase (KatG) from Burkholderia pseudomallei","volume":"345","author":"Deemagarn","year":"2005","journal-title":"J Mol Biol"},{"key":"ref181","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41598-021-04345-x","article-title":"A systematic review and meta-analysis of the catastrophic costs incurred by tuberculosis patients","volume":"12","author":"Ghazy","year":"2022","journal-title":"Sci Rep"},{"key":"ref182","doi-asserted-by":"publisher","first-page":"103714","DOI":"10.1016\/j.micpath.2019.103714","article-title":"Diet and nutrition: an important risk factor in leprosy","volume":"137","author":"Dwivedi","year":"2019","journal-title":"Microb Pathog"},{"key":"ref183","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s40264-015-0267-y","article-title":"Safety and tolerability profile of second-line anti-Tuberculosis medications","volume":"38","author":"Ramachandran","year":"2015","journal-title":"Drug Saf"},{"key":"ref184","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1111\/j.1468-3083.2010.03908.x","article-title":"Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica","volume":"25","author":"Solomon","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref185","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.ijantimicag.2014.01.005","article-title":"Treatment and prophylaxis of melioidosis","volume":"43","author":"Dance","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"ref186","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jctube.2015.09.001","article-title":"Rifampicin-induced nephrotoxicity in a tuberculosis patient","volume":"1","author":"Beebe","year":"2015","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"ref187","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1136\/thoraxjnl-2020-215449","article-title":"Recurrent TB: a systematic review and meta-analysis of the incidence rates and the proportions of relapses and reinfections","volume":"76","author":"Vega","year":"2021","journal-title":"Thorax"},{"key":"ref188","doi-asserted-by":"publisher","first-page":"e0005598","DOI":"10.1371\/journal.pntd.0005598","article-title":"Whole genome sequencing distinguishes between relapse and reinfection in recurrent leprosy cases","volume":"11","author":"Stefani","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"ref189","doi-asserted-by":"publisher","first-page":"e0008429","DOI":"10.1371\/journal.pntd.0008429","article-title":"Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India","volume":"14","author":"Goyal","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"ref190","doi-asserted-by":"publisher","first-page":"e0005411","DOI":"10.1371\/journal.pntd.0005411","article-title":"The epidemiology and clinical features of melioidosis in far North Queensland: implications for patient management","volume":"11","author":"Stewart","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"ref191","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1574-6976.2012.00331.x","article-title":"Mycobacterium tuberculosis: success through dormancy","volume":"36","author":"Gengenbacher","year":"2012","journal-title":"FEMS Microbiol Rev"},{"key":"ref192","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1093\/cid\/ciw670","article-title":"Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the infectious diseases society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)","volume":"63","author":"Aronson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref193","first-page":"205","article-title":"Bacterial persistence in leprosy","volume":"49","author":"Toman","year":"1981","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"ref194","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/10409238.2013.869543","article-title":"Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria","volume":"49","author":"Kester","year":"2014","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"ref195","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1128\/MMBR.00010-14","article-title":"Latent tuberculosis infection: myths, models, and molecular mechanisms","volume":"78","author":"Dutta","year":"2014","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref196","doi-asserted-by":"publisher","first-page":"E801","DOI":"10.1073\/pnas.1619265114","article-title":"Continual renewal and replication of persistent Leishmania major parasites in concomitantly immune hosts","volume":"114","author":"Mandell","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"ref197","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1086\/507543","article-title":"Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes","volume":"43","author":"Nijland","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref198","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1128\/AAC.00447-09","article-title":"Pharmacokinetics of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes","volume":"54","author":"Ruslami","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref199","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S2213-8587(14)70110-X","article-title":"Clinical management of concurrent diabetes and tuberculosis and the implications for patient services","volume":"2","author":"Riza","year":"2014","journal-title":"Lancet Diabet Endocrinol"},{"key":"ref200","doi-asserted-by":"publisher","first-page":"e01383","DOI":"10.1128\/AAC.01383-18","article-title":"Effect of diabetes mellitus on the pharmacokinetics and pharmacodynamics of tuberculosis treatment","volume":"62","author":"Alfarisi","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"ref201","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1440-1843.2010.01902.x","article-title":"Increased prevalence of primary drug-resistant pulmonary tuberculosis in immunocompromised patients","volume":"16","author":"Jiang","year":"2011","journal-title":"Respirology"},{"key":"ref202","doi-asserted-by":"publisher","first-page":"1901891","DOI":"10.1183\/13993003.01891-2019","article-title":"Diabetes is associated with genotypically drug-resistant tuberculosis","volume":"55","author":"Ruesen","year":"2020","journal-title":"Eur Respir J"},{"key":"ref203","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ijid.2019.04.009","article-title":"Potential drug\u2013drug interactions between antiretroviral therapy and treatment regimens for multi-drug resistant tuberculosis: implications for HIV care of MDR-TB co-infected individuals","volume":"83","author":"Mukonzo","year":"2019","journal-title":"Int J Infect Dis"},{"key":"ref204","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/cid\/ciq192","article-title":"Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis","volume":"52","author":"Koh","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref205","doi-asserted-by":"publisher","first-page":"e2500","DOI":"10.1371\/journal.pntd.0002500","article-title":"Glyburide reduces bacterial dissemination in a mouse model of melioidosis","volume":"7","author":"Koh","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref206","author":"Theng","year":"2013"},{"key":"ref207","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1371\/journal.pmed.0040238","article-title":"Patient adherence to tuberculosis treatment: a systematic review of qualitative research","volume":"4","author":"Munro","year":"2007","journal-title":"PLoS Med"},{"key":"ref208","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/00333549101250S407","article-title":"Tuberculosis and stigmatisation: pathways and interventions","volume":"125","year":"2010","journal-title":"Public Health Rep"},{"key":"ref209","doi-asserted-by":"publisher","first-page":"54","DOI":"10.47276\/lr.86.1.54","article-title":"Comparing the perception of community members towards leprosy and tuberculosis stigmatization","volume":"86","author":"Sermrittirong","year":"2015","journal-title":"Lepr Rev"},{"key":"ref210","doi-asserted-by":"publisher","first-page":"65","DOI":"10.47276\/lr.80.1.65","article-title":"Gender and leprosy: case studies in Indonesia, Nigeria, Nepal and Brazil","volume":"80","author":"Varkevisser","year":"2009","journal-title":"Lepr Rev"},{"key":"ref211","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ijid.2016.10.011","article-title":"Tuberculosis stigma as a social determinant of health: a systematic mapping review of research in low incidence countries","volume":"56","author":"Craig","year":"2017","journal-title":"Int J Infect Dis"},{"key":"ref212","doi-asserted-by":"publisher","first-page":"149","DOI":"10.47276\/lr.85.3.149","article-title":"How to reduce stigma in leprosy\u2013a systematic","volume":"85","author":"Sermrittirong","year":"2014","journal-title":"Lepr Rev"},{"key":"ref213","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/bmb\/ldr007","article-title":"Melioidosis: a clinical overview","volume":"99","author":"Limmathurotsakul","year":"2011","journal-title":"Br Med Bull"},{"key":"ref214","year":"2023"},{"key":"ref215","year":"2023"},{"key":"ref216","year":"2023"},{"key":"ref217","year":"2022"},{"key":"ref218","year":"2022"},{"key":"ref219","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/S1473-3099(24)00158-0","article-title":"Global burden associated with 85 pathogens in 2019: a systematic analysis for the global burden of disease study 2019","volume":"24","author":"Naghavi","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"ref220","year":"2023"},{"key":"ref221","year":"2022"},{"key":"ref222","year":"2017"},{"key":"ref223","year":"2023"},{"key":"ref224","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/CMR.00006-19","article-title":"Human melioidosis","volume":"33","author":"Gassiep","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"ref225","volume-title":"Pipeline of vaccines. TuBerculosis Vaccine Initiative","year":"2024"},{"key":"ref226","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-3-031-24355-4_14","volume-title":"Vaccine development for human leishmaniasis. vaccines for neglected pathogens: Strategies, achievements and challenges: focus on leprosy, leishmaniasis, melioidosis and tuberculosis","author":"de Carvalho","year":"2023"},{"key":"ref227","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/978-3-031-24355-4_15","article-title":"Vaccine Development Against Melioidosis","volume-title":"Vaccines for neglected pathogens: Strategies, achievements and challenges: focus on leprosy, leishmaniasis, melioidosis and tuberculosis","author":"Galeas-Pena","year":"2023"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1423420\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T04:21:46Z","timestamp":1726028506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1423420\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":227,"alternative-id":["10.3389\/fpubh.2024.1423420"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2024.1423420","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]},"article-number":"1423420"}}